orderForm.noItems T

he fall in COVID-19 cases across much of the world over the past ten weeks signals a new dawn in the fight against the disease. Vaccines are proving effective and rapidly scaling, bending the curve in many

geographies. This is a fragile dawn, however, with transmission and deaths still high, unequal access to vaccines and variants of concern threatening to undo progress to date. The trajectory of UK and US cases has enabled the

beginnings of a transition toward normalcy,the first and more important of the pandemic’s two endpoints. We expect this transition to continue in the second quarter of 2021 and will likely see many aspects of social and economic life return to the pre-pandemic normal, consistent with UK Prime Minister Johnson’s staged reopening plan for the United Kingdom and US President Biden’s goal of a normal Independence Day. Parts of the European Union have recently faced setbacks: fewer doses in arms than in the United Kingdom or United States, a new wave of cases, and new lockdowns. A transition toward normalcy is mostly likely in Europe during the late second or third quarter of 2021. The timing will probably vary by country, depending on accelerating vaccine supplies, the impact of vaccinations on hospitalization rates, and the occurrence (or not) of new waves driven by new variants. While in-person events are still on the back burner, there are still plenty of virtual events to stay connected with the industry. We are delighted to announce an exciting new partnership with CPhI Discover, a new online event to provide pharmaceutical professionals a way to meet, discuss, partner,

PUBLISHING DIRECTOR Ellie Bruni T: +44 (0) 7872 516194 E:

ADVERTISING Nadia Liefsoens T: +32475593196

EDITORIAL CONTACT Please send your news and suggestions for feature articles to the editorial team at

Chemicals Knowledge Hub is published by BIBO Publishing SL Av. Diagonal, 409, 1St Floor, 08008, Barcelona, Spain

Issue 2 • March/April 2021

source and learn online. This month we will also see the launch of Life Science Knowledge Hub, our new digital platform as well as its latest issue which will feature another top event partnership with Bio Integrates 2021

This issue highlights yet more online events, this time hosted by the US organization SOCMA (Society of Chemical Manufacturers & Affiliates) – SOCMA is inviting speciality and fine chemical companies to showcase their expertise and share capabilities during a series of Manufacturing Solutions Days, the first of four such one-day events this year having already taken place on March 10; and the SOCMA Policy Webinar Series in April in anticipation of new policy and regulations coming under the Biden Administration: this series of events focuses on key topics the organization says are crucial to its membership and the value chain. It’s an interesting time to be in the speciality chemicals industry. But then again…when is it not?


Publishing Director Chemicals Knowledge Hub (Global) Disclaimer

The disclaimer has an error: BIBO Publishing SL will not be held responsible or liable for errors or omissions supplied or contained in this publication, although due care and attention are taken to ensure all content is accurate at the time of going to press. BIBO Publishing SL also will not be held responsible for any false claims made by advertisers, or in articles contributed by external authors.


The contents of this publication are copyright © BIBO Publishing SL 2020. No part of this publication can be reproduced or transmitted in any form without the express permission of the publisher.

ISSN 2516-4481


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64